Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.

Ruscher K, Kuric E, Liu Y, Walter HL, Issazadeh-Navikas S, Englund E, Wieloch T.

J Cereb Blood Flow Metab. 2013 Aug;33(8):1225-34. doi: 10.1038/jcbfm.2013.71. Epub 2013 May 1.

2.

Physical exercise regulates neural stem cells proliferation and migration via SDF-1α/CXCR4 pathway in rats after ischemic stroke.

Luo J, Hu X, Zhang L, Li L, Zheng H, Li M, Zhang Q.

Neurosci Lett. 2014 Aug 22;578:203-8. doi: 10.1016/j.neulet.2014.06.059. Epub 2014 Jul 7.

PMID:
25010020
3.

Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.

Mao L, Huang M, Chen SC, Li YN, Xia YP, He QW, Wang MD, Huang Y, Zheng L, Hu B.

CNS Neurosci Ther. 2014 May;20(5):460-8. doi: 10.1111/cns.12238. Epub 2014 Mar 2.

PMID:
24581269
4.

Effects of chronic Clozapine administration on apolipoprotein D levels and on functional recovery following experimental stroke.

Ruscher K, Erickson A, Kuric E, Inácio AR, Wieloch T.

Brain Res. 2010 Mar 19;1321:152-63. doi: 10.1016/j.brainres.2010.01.024. Epub 2010 Jan 18.

PMID:
20083089
5.

Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.

Cui X, Chen J, Zacharek A, Li Y, Roberts C, Kapke A, Savant-Bhonsale S, Chopp M.

Stem Cells. 2007 Nov;25(11):2777-85. Epub 2007 Jul 19.

6.

CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice.

Huang J, Li Y, Tang Y, Tang G, Yang GY, Wang Y.

Stroke. 2013 Jan;44(1):190-7. doi: 10.1161/STROKEAHA.112.670299. Epub 2012 Nov 20.

7.

CXCR4 antagonist AMD3100 reverses the neurogenesis and behavioral recovery promoted by forced limb-use in stroke rats.

Zhao S, Qu H, Zhao Y, Xiao T, Zhao M, Li Y, Jolkkonen J, Cao Y, Zhao C.

Restor Neurol Neurosci. 2015;33(6):809-21. doi: 10.3233/RNN-150515.

PMID:
26444377
8.

SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.

Wang Y, Deng Y, Zhou GQ.

Brain Res. 2008 Feb 21;1195:104-12. doi: 10.1016/j.brainres.2007.11.068. Epub 2007 Dec 14.

PMID:
18206136
9.

Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.

Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, Chen Y, Su H, Young WL, Yang GY.

Ann Neurol. 2010 Apr;67(4):488-97. doi: 10.1002/ana.21919.

10.

17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia.

Söderström I, Strand M, Ingridsson AC, Nasic S, Olsson T.

Eur J Neurosci. 2009 Mar;29(6):1215-24. doi: 10.1111/j.1460-9568.2009.06662.x.

PMID:
19302156
11.

Effects of postischemic environment on transcription factor and serotonin receptor expression after permanent focal cortical ischemia in rats.

Dahlqvist P, Rönnbäck A, Risedal A, Nergårdh R, Johansson IM, Seckl JR, Johansson BB, Olsson T.

Neuroscience. 2003;119(3):643-52.

PMID:
12809685
12.

The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.

Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, Toresson H, Ruslim-Litrus L, Oksenberg D, Urfer R, Johansson BB, Nikolich K, Wieloch T.

Brain. 2011 Mar;134(Pt 3):732-46. doi: 10.1093/brain/awq367. Epub 2011 Jan 28.

PMID:
21278085
13.

Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.

Kuric E, Wieloch T, Ruscher K.

Exp Neurol. 2013 Sep;247:202-8. doi: 10.1016/j.expneurol.2013.04.016. Epub 2013 May 9.

PMID:
23664961
14.

Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke.

Ruscher K, Johannesson E, Brugiere E, Erickson A, Rickhag M, Wieloch T.

J Cereb Blood Flow Metab. 2009 Nov;29(11):1796-805. doi: 10.1038/jcbfm.2009.96. Epub 2009 Jul 22.

PMID:
19623195
15.

Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke.

Walter HL, van der Maten G, Antunes AR, Wieloch T, Ruscher K.

J Neuroinflammation. 2015 Feb 7;12:24. doi: 10.1186/s12974-014-0232-1.

16.

Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke.

Inácio AR, Ruscher K, Wieloch T.

Neurobiol Dis. 2011 Feb;41(2):270-8. doi: 10.1016/j.nbd.2010.09.015. Epub 2010 Sep 29.

PMID:
20883785
17.

Sodium Ferulate combined with bone marrow stromal cell treatment ameliorating rat brain ischemic injury after stroke.

Zhao Y, Guan Y, Xu Y, Li Y, Wu W.

Brain Res. 2012 Apr 23;1450:157-65. doi: 10.1016/j.brainres.2012.02.053. Epub 2012 Mar 1.

PMID:
22424793
18.
19.

Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.

Pérez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P.

Neurobiol Dis. 2005 Mar;18(2):375-84.

PMID:
15686966
20.

Levodopa treatment improves functional recovery after experimental stroke.

Ruscher K, Kuric E, Wieloch T.

Stroke. 2012 Feb;43(2):507-13. doi: 10.1161/STROKEAHA.111.638767. Epub 2011 Nov 17.

Supplemental Content

Support Center